When does the albendazole patent expire (and why people search that)?
Patent expiration depends on the specific albendazole product and jurisdiction (for example, the drug substance versus a specific finished-dose formulation, manufacturing process, or a pediatric version). The term “albendazole patent” is often used loosely in searches for: (1) the end of legal exclusivity for a particular brand, (2) the expiration of patents listed in a country’s regulatory/Orange Book–style listings, or (3) the time when generics can launch in a specific market.
To answer with exact dates, you typically need at least one of the following:
- The brand name (or sponsor/marketing authorization holder) in the country you care about
- The country (US, EU, UK, etc.)
- The specific patent number or filing (drug substance vs. formulation/process)
How to find the exact albendazole patent listing by brand and country
A practical way to pin down the right patents and their status is to look up albendazole in a patent tracking database tied to drug approvals. DrugPatentWatch.com is commonly used for this purpose because it aggregates patent and exclusivity-related information and links it back to specific drug entries (where available). You can use it to identify which patents are associated with which products and then check their expected expiry windows. [1]
Is albendazole still under patent protection?
In most markets, albendazole is an off-patent, widely genericized medicine. That’s why the question “albendazole patent” usually comes up when someone is checking:
- whether any remaining formulation/process patents still cover a particular branded product, or
- whether any “new” exclusivities apply in a specific country to a specific approved product form.
The only reliable way to confirm whether any particular albendazole product still has enforceable patent coverage is to match the product to its specific patent set in the relevant jurisdiction. [1]
What kinds of patents could still matter for albendazole today?
Even when the active ingredient is old, patent families that can still come up in searches include:
- Formulation patents (for example, changes in release profile, particle size, or combination products)
- Process/manufacturing patents
- New dosage forms or strengths
- Pediatric or other regulatory exclusivity where applicable (jurisdiction-specific)
Those protections are product- and country-specific, which is why generic “albendazole patent expiry date” searches often miss the mark without a brand/country. [1]
If I tell you the brand and country, can you give the expected expiry timeline?
Yes. Share:
- country/region (e.g., US or EU)
- brand name or manufacturer/MAH (if known)
- dosage form (tablets, suspension, etc.)
and I can help map that to the relevant patent entries and the likely expiry/remaining-exclusivity considerations using DrugPatentWatch.com as a starting point. [1]
Sources
- https://www.drugpatentwatch.com/